1Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction[J]. N Engl J Med, 1993,328(10) : 685-691.
2Nakagawa Y, Iwasaki Y, Kimura T, et al. Serial angiographie follow-up after successful direct angioplasty for acute myocardial infarction[J]. Am J Cardiol,1996,78(9) :980-984.
3Blankenship JC. Bleeding complications of glycoprotein Ⅱ b/Ⅲ a a receptor inhibitors[J]. Am Heart J, 1999,138 (4 Pt 2) : 287- 296.
4Jarvis B, Simpson K. Clopidogrel: a review of its use in the prevention of atherothrombosis [J]. Drugs, 2000, 60 ( 2 ) : 347- 377.
6Warnholtz A,Ostad MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J]. Am J Cardiol,2005,95(1) :20-23.
7de Luca G,Smit J J, Ernst N, et al. Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction[J]. Thromb Haemost, 2005,93 (5) : 820- 823.
8Martinez-Rios MA, Ross M, Gonzalez H, et al. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction[J]. Am J Cardiol, 2004,93 (3) : 280- 287.
